斯诺RNAs在人类疾病中的新兴作用
Xinhai Zhang1, Chenglong Wang1, Shujun Xia2
1Department of Orthopedic Surgery, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine (SJTUSM), Shanghai 200092, China.
Genes & diseases
|July 26, 2023
概括
小核RNAs (snoRNAs) 对生物过程和疾病调节至关重要. 研究正在揭示它们在核糖体修饰之外的多样性作用,突出显示它们在疾病发病和治疗方面的潜力.
科学领域:
- 分子生物学分子生物学
- 基因组学就是基因组学.
- 疾病机制 疾病机制
背景情况:
- 小核RNAs (snoRNAs) 是重要的非编码RNAs,参与细胞功能.
- 传统上被分类为C/D盒和H/ACA盒snoRNAs,它们已知的作用包括rRNA修饰.
- 最近的发现揭示了具有未确定功能的snoRNAs,这表明了更广泛的生物学意义.
研究的目的:
- 审查snoRNAs在各种生物过程中的多方面的作用.
- 探索snoRNA失调和人类疾病之间的关联.
- 强调snoRNAs作为治疗标和生物标记物的潜力.
主要方法:
- 关于snoRNAs和疾病调节的最新研究的文献综述.
- 综合了关于已建立和新兴snoRNA功能的发现.
- 分析snoRNA表达模式与疾病发病之间的联系.
主要成果:
- 斯诺RNAs涉及到除了核糖体生物发生之外的广泛的生物过程.
- 异常的snoRNA表达与许多人类疾病有关.
- 越来越多的snoRNA缺乏明确的目标或功能,表明尚未探索的角色.
结论:
- 斯诺RNAs代表了理解疾病机制的一个有希望的领域.
- 对snoRNA功能的进一步研究可以确定新的生物标志物.
- 斯诺RNA具有开发新治疗策略的巨大潜力.
相关概念视频
lncRNA - Long Non-coding RNAs
8.6K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.6K
siRNA - Small Interfering RNAs
16.8K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
16.8K
Alternative RNA Splicing
21.4K
Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
21.4K
MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
RNA Splicing
56.5K
Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
56.5K
RNA Interference
26.1K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
26.1K


